SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-355607
Filing Date
2012-08-14
Accepted
2012-08-14 16:15:03
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d352635d10q.htm 10-Q 214270
2 EX-10.15 d352635dex1015.htm EX-10.15 9424
3 EX-31.1 d352635dex311.htm EX-31.1 6937
4 EX-31.2 d352635dex312.htm EX-31.2 6676
5 EX-32.1 d352635dex321.htm EX-32.1 7074
  Complete submission text file 0001193125-12-355607.txt   1846288

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srne-20120630.xml EX-101.INS 156265
7 XBRL TAXONOMY EXTENSION SCHEMA srne-20120630.xsd EX-101.SCH 21018
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20120630_cal.xml EX-101.CAL 24516
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20120630_def.xml EX-101.DEF 58975
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20120630_lab.xml EX-101.LAB 180906
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20120630_pre.xml EX-101.PRE 123178
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52228 | Film No.: 121033049
SIC: 8731 Services-Commercial Physical & Biological Research